Bionovo to Present at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference
EMERYVILLE, Calif., July 29 /PRNewswire-FirstCall/ -- Bionovo, Inc.
(Nasdaq: BNVI), a drug discovery and development company focused on the unmet
needs in women's health and oncology, today announced that Dr. Mary
Tagliaferri, President and Chief Medical Officer, and Tom Chesterman, Senior
Vice President and CFO, will be presenting at the BMO Capital Markets Ninth
Annual Focus on Healthcare Conference at 1:45 p.m. EDT on Wednesday, August 5,
2009. The event will be held at the Millennium Broadway Hotel in New York
Interested parties can access a live webcast of the presentation by
visiting http://www.bmocm.com/conferences/2009healthcare/webcast/. A replay
will be available for 6 months following the conference.
About Bionovo, Inc.
Bionovo, Inc. is a pharmaceutical company focused on the discovery and
development of safe and effective treatments for women's health and cancer,
markets with significant unmet needs and billions in potential annual revenue.
The company applies its expertise in the biology of menopause and cancer to
design new drugs derived from botanical sources which have novel mechanisms of
action. Based on the results of early and mid-stage clinical trials, Bionovo
believes they have discovered new classes of drug candidates within their rich
pipeline with the potential to be leaders in their markets. Bionovo is
headquartered in Emeryville, California and is traded on the NASDAQ Capital
Market under the symbol, "BNVI". For more information about Bionovo and its
programs, visit: http://www.bionovo.com.
SOURCE Bionovo, Inc.
/CONTACT: Claire Fong or Tom Chesterman, Both of Bionovo, Inc.,
+1-510-601-2000, email@example.com; Investors, Joe Diaz, Robert Blum or Joe
Dorame, Lytham Partners, LLC, +1-602-889-9700, firstname.lastname@example.org, For
/Web Site: http://www.bionovo.com /
CO: Bionovo, Inc.
IN: MTC HEA
-- SF53434 --
5034 07/29/2009 09:00 EDT http://www.prnewswire.com